MGP Ingredients (MGPI) Tops Q3 EPS by 4c, provides outlook

MGP Ingredients (NASDAQ: MGPI) reported Q3 EPS of $1.34, $0.04 better than the analyst estimate of $1.30. Revenue for the quarter came in at $211.6 million versus the consensus estimate of $209.14 million.

FY23 Outlook:
Sales are projected to be in the range of $815 million to $835 million vs. the consensus of $827.2M.

Adjusted EBITDA is expected to be in the range of $192 million to $197 million.
Adjusted basic EPS is forecasted to be in the $5.50 to $5.65 range vs. the consensus of $5.43.

For earnings history and earnings-related data on MGP Ingredients (MGPI) click here.

You May Also Be Interested In

• Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
• Oppenheimer Starts Teva Pharma (TEVA) at Outperform
• Oppenheimer Starts Viatris (VTRS) at Outperform